NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4): 40,000 Ordinary Shares Granted to Two Non-Executive New Hires.

viernes, 5 de diciembre de 2025, 4:02 pm ET1 min de lectura
NAMS--

NewAmsterdam Pharma announced the grant of inducement share options to two new hires under Nasdaq Listing Rule 5635(c)(4). The options cover 40,000 shares, with an exercise price of $39.61 and a vesting period of four years. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam Pharma.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4): 40,000 Ordinary Shares Granted to Two Non-Executive New Hires.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios